- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 37.38M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $363.73M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $355.31M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $19.65M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $19.65M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $35.3M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $32.22M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $162.58M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $147.11M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $606.42M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $583.3M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $289.14M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $259.31M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $883.84M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $860.82M |
| Total Assets | Q1 2025 · Mar 31, 2024 | $947.14M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 37.12M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $5.35M |
| Capex | Q1 2025 · Mar 31, 2024 | $5.71M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $20.27M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $291.65M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $292.8M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.09 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.09 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $47.11M |
| Net Income | Q1 2025 · Mar 31, 2024 | $3.5M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $10.88M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $64.27M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $142.83M |
| Revenue | Q1 2025 · Mar 31, 2024 | $207.1M |